65,437 trials
Respiratory Complication
Primary: Number of Patients With Adverse Events Following LMA Removal — 10; 5; 1; 0 participants
Bone Marrow Aspiration and Biopsy Specimen Collection
Primary: Percent of Hematopoietic Tissue Present in Bone Marrow Biopsy Specimens Obtained Using the Manual Device and Powered Device — 42.5; 55.8 % Hematopoetic tissue present…
Bladder Cancer
Primary: Detecting the Rate of Bladder Cancer Lesions by White-Light Cystoscopy (WLC) and Blue-Light Cystoscopy (BLC) With Hexvix® in the Overall Study Population by Comparison…
Diffuse Large B-Cell Lymphoma
Primary: Objective Response Rate — 2; 0 Patients
Familial Adenomatous Polyposis Coli · FAP
Primary: Absolute Change in the Number of Polyps Measured in a Focal Area of the Rectum. — -0.5; 0.5 Change from baseline number of polyps. — p=0.005
Stress Disorders · Post-Traumatic
Primary: Change in CAPS Score From Baseline to Week 24 — -16.3; -12.5 units on a scale
Leishmaniasis, Cutaneous
Primary: Final Clinical Cure for Index Lesions — 11; 9 participants
Drug Interactions
Primary: Plasma AUC Ratio of Day 1 and Day 8 — 1.093; 1.029; 1.104; 1.914 Ratio of geometric means Day 8 to Day 1
Pain
Primary: Musculoskeletal Discomfort — 20; 20 percentage of subjects with MSD — p=>.05
Arterial Hypertension
Primary: Efficacy of Hypertension Treatment on Systolic Blood Pressure (SBP) — 11.8; 9.7; 9.9 percent change
Cataract · Astigmatism
Primary: Percent Reduction in Absolute Cylinder — 84.975; 46.498 percentage of intended cylinder reduct
Osteoarthritis
Primary: Changes in Postoperative Pain Scores — 2.7; 2.5; 0.9; 1.5 units on a scale
Childhood Burkitt Lymphoma · Childhood Diffuse Large Cell Lymphoma · Childhood Immunoblastic Large Cell Lymphoma
Primary: Grade ≥ 3 Stomatitis — 4; 6; 41; 34 participants
Delirium
Primary: Percentage of Participants With Delirium Using the CAM Over Time — 14; 44; 64; 64 percentage of participants
Fabry Disease
Primary: Change From Baseline in Left Ventricular Mass Indexed to Height (LVMI) — -0.75 g/m^2.7